These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 36707778)

  • 1. A survey with interventional components delivered on tablet devices versus usual care to increase pre-exposure prophylaxis uptake among cisgender Black women: a pilot randomized controlled trial.
    Hill MJ; Heads AM; Suchting R; Stotts AL
    BMC Infect Dis; 2023 Jan; 23(1):57. PubMed ID: 36707778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrEP Chicago: A randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men.
    Young LE; Schumm P; Alon L; Bouris A; Ferreira M; Hill B; Khanna AS; Valente TW; Schneider JA
    Clin Trials; 2018 Feb; 15(1):44-52. PubMed ID: 28862483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Randomized Controlled Pilot Study of Just4Us, a Counseling and Navigation Intervention to Promote Oral HIV Prophylaxis Uptake Among PrEP-Eligible Cisgender Women.
    Teitelman AM; Tieu HV; Chittamuru D; Shaw PA; Nandi V; Davis A; Lipsky RK; Darlington CK; Fiore D; Koblin BA
    AIDS Behav; 2023 Sep; 27(9):2944-2958. PubMed ID: 36869921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embedding a Linkage to Preexposure Prophylaxis Care Intervention in Social Network Strategy and Partner Notification Services: Results From a Pilot Randomized Controlled Trial.
    Teixeira da Silva D; Bouris A; Ramachandran A; Blocker O; Davis B; Harris J; Pyra M; Rusie LK; Brewer R; Pagkas-Bather J; Hotton A; Ridgway JP; McNulty M; Bhatia R; Schneider JA
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):191-199. PubMed ID: 33109935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial.
    Goddard-Eckrich D; McCrimmon T; Bond K; Chang M; Hunt T; Hall J; Russo M; Ramesh V; Johnson KA; Downey DL; Wu E; El-Bassel N; Gilbert L
    Addict Sci Clin Pract; 2024 Jul; 19(1):55. PubMed ID: 39039560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorating Racial Disparities in HIV Prevention via a Nurse-Led, AI-Enhanced Program for Pre-Exposure Prophylaxis Utilization Among Black Cisgender Women: Protocol for a Mixed Methods Study.
    Zhang C; Wharton M; Liu Y
    JMIR Res Protoc; 2024 Aug; 13():e59975. PubMed ID: 39137028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing Urban African American Women's Readiness for Pre-exposure Prophylaxis: A Pilot Study of the Women Prepping for PrEp Plus Program (WP3+).
    Wyatt GE; Norwood-Scott E; Cooley-Strickland M; Zhang M; Smith-Clapham A; Jordan W; Liu H; Hamilton AB
    Womens Health Issues; 2024; 34(3):241-249. PubMed ID: 38267337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trial.
    Thomas R; Skovdal M; Galizzi MM; Schaefer R; Moorhouse L; Nyamukapa C; Maswera R; Mandizvidza P; Hallett TB; Gregson S
    Trials; 2019 Dec; 20(1):668. PubMed ID: 31791405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    Mugwanya KK; Pintye J; Kinuthia J; Abuna F; Lagat H; Begnel ER; Dettinger JC; John-Stewart G; Baeten JM;
    PLoS Med; 2019 Sep; 16(9):e1002885. PubMed ID: 31479452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of multiple data sources for predicting increased need for HIV prevention among cisgender women: understanding missed opportunities for Pre-exposure Prophylaxis (PrEP).
    Johnson AK; Devlin S; Haider S; Oehler C; Rivera J; Alvarez I; Ridgway J
    BMC Infect Dis; 2023 Nov; 23(1):781. PubMed ID: 37946103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT).
    Ridgway JP; Devlin SA; Friedman EE; Enaholo OE; Pyra M; Hirschhorn LR; Haider S; Ducheny K; Johnson AK
    PLoS One; 2023; 18(5):e0285858. PubMed ID: 37196008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.
    Hirschhorn LR; Brown RN; Friedman EE; Greene GJ; Bender A; Christeller C; Bouris A; Johnson AK; Pickett J; Modali L; Ridgway JP
    J Acquir Immune Defic Syndr; 2020 Aug; 84(5):497-507. PubMed ID: 32692108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-Exposure Prophylaxis Perspectives, Sociodemographic Characteristics, and HIV Risk Profiles of Cisgender Women Seeking and Initiating PrEP in a US Demonstration Project.
    Blumenthal J; Landovitz R; Jain S; He F; Kofron R; Ellorin E; Ntim GM; Stockman JK; Corado K; Rivet Amico K; Moore DJ; Morris S
    AIDS Patient Care STDS; 2021 Dec; 35(12):481-487. PubMed ID: 34851726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Awareness, Acceptability, and Adoption of Conventional and non-conventional Forms of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention Among jail-involved Black Sexual Minority men (BSMM) and Black Transgender Women (BTW) in Two Diverse US Cities.
    Jones MD; Jones K; Almirol E; Payne G; Graves B; Schneider JA; Rijos D; Zawitz C; Zimmerman R; Seal DW; Brewer R; DrPH RB
    AIDS Behav; 2023 Apr; 27(4):1304-1313. PubMed ID: 36264406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "PrEP"ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women.
    Pasipanodya EC; Stockman J; Phuntsog T; Morris S; Psaros C; Landovitz R; Amico KR; Moore DJ; Blumenthal J
    BMC Womens Health; 2021 May; 21(1):220. PubMed ID: 34034719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking women experiencing incarceration to community-based HIV pre-exposure prophylaxis care: protocol of a pilot trial.
    Ramsey SE; Ames EG; Brinkley-Rubinstein L; Teitelman AM; Clarke J; Kaplan C
    Addict Sci Clin Pract; 2019 Mar; 14(1):8. PubMed ID: 30832717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol of a randomized controlled trial to assess the efficacy of the "PrEPare for Work" intervention to enhance PrEP uptake and optimize adherence for HIV prevention among male sex workers in the U.S.
    Biello KB; Chan PA; Ndoye CD; Nelson L; Nelson E; Silva V; Kwak E; Napoleon S; Cormack Orellana C; Richards OG; Davis E; Mimiaga MJ
    BMC Public Health; 2024 Feb; 24(1):424. PubMed ID: 38336731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "PrEP's just to secure you like insurance": a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi.
    Willie TC; Monger M; Nunn A; Kershaw T; Stockman JK; Mayer KH; Chan PA; Adimora AA; Mena LA; Knight D; Philllips KA; Baral SD
    BMC Infect Dis; 2021 Oct; 21(1):1102. PubMed ID: 34702165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.